The plan, which is not finalized, suggests children get fewer shots and shifts to a model telling parents to consult doctors ...

The agency’s high-level turnover and conflicting policy decisions on drug oversight have fueled concerns about the leadership ...

After patient deaths from interstitial lung disease in a lung cancer trial testing the antibody-drug conjugate ifinatamab deruxtecan, the FDA placed a partial hold on Daiichi Sankyo and Merck's global ...

A strict new vaccine approval process in the U.S. could dramatically slow things down for biopharma and the public, experts ...

UNC's Barry Popkin joins Aaron to discuss the health impacts of "ultra-processed foods" and what policymakers should be doing ...

Biostatistician Jeffrey Morris discusses his analysis of the vaccine monitoring system — and how it could be improved.

A recent memo from Dr. Vinay Prasad​, the head of the FDA's Center for Biologics Evaluation and Research, may signal an ...

Dr. Vinay Prasad: "The establishment, the people who set the policies, they have to strive to get things right. They need to do studies. They need to be held to the highest standard." ...

The Utah plastic surgeon faced up to 35 years in prison if the jury found him guilty on charges that included conspiracy to defraud the United States. Testimony had paused for the weekend when Moore’s ...

Missouri’s top prosecutor said China is suing after the state pressed federal officials for help collecting on a roughly $25 ...